WFA
DVAX

Wipfli Financial Advisors’s Dynavax Technologies DVAX Stock Holding History

Wipfli Financial Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$8K Buy
+784
New +$10.2K ﹤0.01% 1914

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wipfli Financial Advisors's DVAX Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Dynavax Technologies (DVAX) in Q3 2022: 784 shares worth $8K. The stake represents ﹤0.01% of the portfolio and ranks #1914 among its holdings.

236 funds tracked by Wall St. Rank hold DVAX as of Q3 2022.

  • Wipfli Financial Advisors held 784 shares of Dynavax Technologies worth $8K as of Q3 2022.
  • Dynavax Technologies was a new Wipfli Financial Advisors position in Q3 2022.
  • Dynavax Technologies made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #1914 holding.
  • 236 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.